1) Amminger GP, Schaier MR, Papageorgiou K, et al:Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders:A randomized, placebo-controlled trial. Arch Gen Psychiatry 67:146-154, 2010
2) Amminger GP, McGorry PD:Update on omega-3 polyunsaturated fatty acids in early stage psychotic disorders. Neuropsychopharmacology 37:309-310, 2012
3) Argo TR, Crismon ML, Miller AL, et al:The Texas Medication Algorithm Project procedural Manual. Schizophrenia treatment algorithms. Texas Department of State Health Services, 2008
4) Bechdolf A, Wagner M, Ruhrmann S, et al:Preventing progression to first-episode psychosis in early initial prodromal states. Br J Psychiatry 200:22-29, 2012, doi:10.1192/bjp. bp.109.066357. Epub 2011 Nov 10
5) Birchwood M, Todd P, Jackson C:Early intervention in psychosis:The critical period hypothesis. Br J Psychiatry 172(Suppl 33):53-59, 1998
6) Bowie CR, Grossman M, Gupta M, et al:Cognitive remediation in schizophrenia:Efficacy and effectiveness in patients with early versus long-term course of illness. Early Interv Psychiatry 8:32-38, 2014, doi:10.1111/eip.12029. Epub 2013 Jan 24
7) Brtolote J, McGorry P:Early intervention and recovery for young people with early psychosis:Consensus statement. Br J Psychiatry (Supple) 187:s116-s119, 2005, doi:10.1192/bjp.187.48. s116
8) Chen EYH, Lee H, Chan GHK, et al:Early Psychosis Intervention. In:A Culturally Adaptive Clinical Guideline. Hong Kong University Press. Hong Kong, 2013
9) Chen FP, Gearing RE, DeVylder JE, et al:Pathway model of parental help seeking for adolescents experiencing first-episode psychosis. Early Interv Psychiatry, doi:10.1111/eip.12159[Epub ahead of print]
10) Chong SA, Lee C, Bird L, et al:A risk reduction approach for schizophrenia:The Early Psychosis Intervention Programme. Ann Acad Med Singapore 33:630-635, 2004
11) Chong SA, Subramanian M, Lum A, et al:Determinants of duration of untreated psychosis and the pathway to care in Singapore. Int J Soc Psychiatry 51:55-62, 2005
12) Chong SA, Mythily S, Verma S:Reducing the duration of untreated psychosis and changing help-seeking behavior in Singapore. Soc Psychiatry Psychiatr Epidemiol 40:619-621, 2005
13) Choo CH, Verma S, Chong SA:Delusions, prossession or imagination?:Experiencing and recovering from psychosis/Early Psyhosis Intervention Programme. SNP Corporation, Singapore, 2003
14) Cornblatt BA, Lencz T, Smith CW, et al:Can antidepressants be used to treat the schizophrenia prodrome? Results of a prospective, naturalistic treatment study of adolescents. J Clin Psychiatry 68:546-557, 2007
15) Department of Health:Mental health promotion and mental illness prevention:The economic case. Martin Knapp, David McDaid, Michael Parsonage, eds. Department of Health, London, 2011
16) Eack SM, Hogarty GE, Cho RY, et al:Neuroprotective effects of cognitive enhancement therapy against gray matter loss in early schizophrenia:Results from a 2-year randomized controlled trial. Arch Gen Psychiatry 67:674-682, 2010, doi:10.1001/archgenpsychiatry. 2010.63. Epub 2010 May 3
17) Flyckt L, Mattsson M, Edman G, et al:Predicting 5-year outcome in first-episode psychosis:Construction of a prognostic rating scale. J Clin Psychiatry 67:916-924, 2006
18) Fusar-Poli P, Bonoldi I, Yung AR, et al:Predicting psychosis:Meta-analysis of transition outcomes in individuals at high clinical risk. Arch Gen Psychiatry 69:220-229, 2012
19) Fusar-Poli P, Bechdolf A, Taylor MJ, et al:At risk for schizophrenic or affective psychoses? A meta-analysis of DSM/ICD diagnostic outcomes in individuals at high clinical risk. Schizophr Bull 39:923-932, 2013
20) Fusar-Poli P, Borgwardt S, Bechdolf A, et al:The psychosis high-risk state:A comprehensive state-of-the-art review. JAMA Psychiatry 70:107-120, 2013
21) Haahr U, Friis S, Larsen TK, et al:First-episode psychosis:Diagnostic stability over one and two years. Psychopathology 41:322-329, 2008
22) 原田雅典,前川早苗,濱幸伸,他:日本における早期介入の実践モデル.臨床精神医学41:1481-1488, 2012
23) Hastrup LH, Kronborg C, Bertelsen M, et al:Cost-effectiveness of early intervention in first-episode psychosis:Economic evaluation of a randomised controlled trial(the OPUS study). Br J Psychiatry 202:35-41, 2013, doi:10.1192/bjp. bp.112.112300
24) Hegelstad WV, Larsen TK, Auestad B, et al:Long-term follow-up of the TIPS early detection in psychosis study:Effects on 10-year outcome. Am J Psychiatry 169:374-380, 2012
25) 市橋香代,宮越裕治:【精神病早期介入のエビデンス:アップデート】教育との連携—精神病早期介入から児童・生徒の精神保健へ.臨床精神医学41:1449-1454, 2012
26) International-Early-Psychosis-Association-Writing-Group:International clinical practice guidelines for early psychosis. Br J Psychiatry 48(Suppl):s120-s124, 2005
27) Ising HK, Smit F, Veling W, et al:Cost-effectiveness of preventing first-episode psychosis in ultra-high-risk subjects:Multi-centre randomized controlled trial. Psychol Med 21:1-12, 2014[Epub ahead of print]
28) Jackson HJ, McGorry PD, eds:The recognition and management of early psychosis:A preventive approach, second edition. Cambridge University Press, New York, 2009(水野雅文,鈴木道雄,岩田仲生監訳:早期精神病の診断と治療.医学書院,2010)
29) Jorm AF, Nakane Y, Christensen H, et al:Public beliefs about treatment and outcomes of mental disorders:A comparison of Australia and Japan. BMC Medicine 3:12, 2005
30) Kane JM:Tardive dyskinesia rates with atypical anti-psychosis in adults:Prevalence and incidence. J Clin Psychiatry 65:16-20, 2004
31) 桂雅宏,小原千佳,松本和紀:精神病アットリスク(ARMS)に対する早期介入.臨床精神医学41:1413-1419, 2012
32) 厚生労働科学研究補助金障害者対策総合研究事業:統合失調症の未治療期間とその予後に関する疫学的研究(H20-こころ-一般-010)平成20年度—22年度総合研究報告書(研究代表者 水野雅文).pp7-34, 2011
33) Lanbert M, Conus P, Lambert T, et al:Pharmacotherapy of first-episode schizophrenia. Expert Opinion on Pharmacotherapy 4:717-751, 2003
34) Lanbert M, Conus P, Lubman DI, et al:The impact of substance use disorders on clinical outcome in 643 patients with first-episode psychosis. Acta Psychiatrica Scandinavia 112:141-148, 2005
35) Lee RS, Redoblado-Hodge MA, Naismith SL, et al:Cognitive remediation improves memory and psychosocial functioning in first-episode psychiatric out-patients. Psychol Med 43:1161-1173, 2013, doi:10.1017/S0033291712002127
36) Leucht S, Cipriani A, Spinel L, et al:Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia:A multiple-treatments meta-analysis. Lancet 382:951-962, 2013
37) Marshall M, Lewis S, Lockwood A, et al:Association between duration of untreated psychosis and outcome in cohorts of first-episode patients. Arch Gen Psychiatry 62:975-983, 2005
38) 松本和紀,濱家由美子,光永憲香,他:サイコーシス早期段階におけるCBTの活用.精神経誌115:390-398, 2013
39) Mattsson M, Lawoko S, Cullberg J, et al:Background factors as determinants of satisfaction with care among first-episode psychosis patients. Soc Psychiatry Psychiatric Epidemiol 40:749-754, 2005
40) McFarlane WR, Levin B, Travis L, et al:Clinical and functional outcomes after 2 years in the early detection and intervention for the prevention of psychosis multisite effectiveness trial. Schizophr Bull 41:30-43, 2015, doi:10.1093/schbul/sbu108, Epub 2014 Jul 26
41) McGlashan TH, Zipursky RB, Perkins D, et al:The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. Ⅰ. Study rationale and design. Schzophrenia Res 61:7-18, 2003
42) McGlashan TH, Zipursky RB, Perkins D, et al:Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. Am J Psychiatry 185:291-297, 2004
43) McGorry, PD, Edwards J, Mihalopoulos C, et al:EPPIC:An evolving system of early detection and optimal management. Schizophr Bull 22:305-326, 1996
44) McGorry PD, Yung AR, Phillips LJ, et al:Randomized control trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arc Gen Psychiatry 59:921-928, 2002
45) McGorry PD, Nelson B, Phillips LJ, et al:Randomized controlled trial of interventions for young people at ultra-high risk of psychosis:Twelve-month outcome. J Clin Psychiatry 74:349-356, 2013
46) Miklowitz DJ, O' Brien MP, Schlosser DA, et al:Family-focused treatment for adolescents and young adults at risk for psychosis:Results of a randomized trial. J Am Acad Child Adolesc Psychiatry 53:848-858, 2014, doi:10.1016/j. jaac[Epub ahead of print]
47) MindMatters:Resource kit. A mental health promotion program for secondary schools commonwealth department of health and aged care. Australian Principals Associations Professional Development Council. MindMatters. http://www.mindmatters.edu.au/
48) Morokuma I, Shimodera S, Fujita H, et al:Psychoeducation for major depressive disorders:A randomized controlled trial. Psychiatry Res 210:134-139, 2013
49) Nakane Y, Jorm A, Yoshioka K, et al:Public beliefs about causes and risk factors for mental disorders:A comparison of Japan and Australia. BMC Psychiatry 5:33, 2005
50) 中根允文,吉岡久美子,中根秀之:心のバリアフリーを目指して.勁草書房,2010
51) 中根允文,三根真理子:精神障害に係るAnti-stigmaの研究 教科書に見るメンタルヘルス教育—中学校・高等学校の教科書における記載を通して(1950〜2002年までの「保健体育」教科書調査から).日社会精神医会誌22:452-473, 2013
52) NICE(2014). Psychosis and schizophrenia in adults. The NICE guideline on treatment and management. Updated edition 2014:National Collaborating Centre for Mental Health
53) Park AL, McCrone P, Knapp M:Early intervention for first-episode psychosis:Broadening the scope of economic estimates. Early Interv Psychiatry. 2014 Apr 17, doi:10.1111/eip.12149.[Epub ahead of print]
54) Perkins DO, Gu H, Boteva K, et al:Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia:A critical review and meta-analysis. Am J Psychiatry 162:1785-1804, 2005
55) Phillips LJ, Nelson B, Yuen HP, et al:Randomized controlled trial of interventions for young people at ultra-high risk of psychosis:Study design and baseline characteristics. Aust NZ J Psychiatry 43:818-829, 2009
56) Poon LY, Tay E, Lee YP, et al:Making in-roads across the youth mental health landscape in Singapore:The Community Health Assessment Team(CHAT). Early Interv Psychiatry, 2014 Oct 2, doi:10.1111/eip.12192 [Epub ahead of print]
57) Rauchensteiner S, Kawohl W, Ozgurdal S, et al:Test-performance after cognitive training in persons at risk mental state of schizophrenia and patients with schizophrenia. Psychiatry Res 185:334-339, 2011, doi:10.1016/j. psychres. 2009.09.003.
58) Remington G, Kapur S, Zipursky RB:Pharmacotherapy of first-episode schizophrenia. Br J Psychiatry 172:66-70, 1998
59) Sado M, Inagaki A, Koreki A, et al:The cost of schizophrenia in Japan. Neuropsychiatr Dis Treat 201:787-798, 2013
60) Schlogelhofer M, Amminger GP, Schaier MR, et al:Polyunsaturated fatty acids in emerging psychosis:A safer alternative? Early Interv Psychiatry 8:199-208, 2014
61) Schultze-Lutter F, Ruhrmann S, Fusar-Poli P, et al:Basic symptoms and the prediction of first-episode psychosis. Curr Pharm Des 18:351-357, 2012
62) Secher RG, Hjorthøj CR, Austin SA, et al:Ten-year follow-up of the OPUS specialized early intervention trial for patients with a first episode of psychosis. Schizophr Bull, 2014 Nov 7. pii:sbu 155. [Epub ahead of print]
63) Shimazu K, Shimodera S, Mino Y, et al:Family psychoeducation for major depression:Randomised controlled trial. Br J Psychiatry198:385-390, 2011
64) Stafford MR, Jackson H, Myo-Wilson E, et al:Early interventions to prevent psychosis:Systematic review and meta-analysis. BMJ 346:f185, 2013
65) Tay SA, Yuen S, Lim LK, et al:Support for Wellness Achievement Programme(SWAP):Clinical and demographic characteristics of young people with at-risk mental state in Singapore. Early Interv Psychiatry, 2014 Sep 9, doi:10.1111/eip. 12176
66) 坪井貴嗣,稲垣中:初回エピソード統合失調症の薬物療法.水野雅文編:前駆期における薬物療法.専門医のための精神臨床リュミエール5,統合失調症の早期診断と早期介入.中山書店,pp138-150,2008
67) Valmaggia LR, McGuire PK, Fusar-Poli P, et al:Economic impact of early detection and early intervention of psychosis. Curr Pharm Des 18:592-595, 2012
68) van der Gaag M, Smit F, Bechdolf A, et al:Preventing a first episode of psychosis:Meta-analysis of randomized controlled prevention trials of 12 month and longer-term follow-ups. Schizophr Res 149:56-62, 2013, doi:10.1016/j. schres. 2013.07.004.
69) van Haren NE, Cahn W, Hulshoff Pol HE, et al:The course of brain abnormalities in schizophrenia:Can we slow the progression? J Psychopharmacol 26(Suppl 5):8-14, 2012, doi:10.1177/0269881111408964.
70) Verma S, Lye YP, Subramanian M, et al:The Singapore Early Psychosis Intervention Programme(EPIP):A programme evaluation. Asian J Psychiatr 5:63-67, 2012
71) 山澤涼子:精神病未治療期間(DUP)と初回エピソード統合失調症.水野雅文編:前駆期における薬物療法.専門医のための精神臨床リュミエール5,統合失調症の早期診断と早期介入.中山書店,pp88-95,2008
72) Yung AR, McGorry PD, McFarlane CA, et al:Monitoring and care of young people at incipient risk of psychosis. Schizophr Bull 22:283-303, 1996
73) Yung AR, Woods SW, Ruhrmann S, et al.:Whither the attenuated psychosis syndrome? Schizophr Bull 38:1130-1134, 2012
74) Yung AR, Phillips LJ, Nelson B, et al:Randomized controlled trial of interventions for young people at ultra-high risk of psychosis:6-month analysis. J Clin Psychiatry 72:430-440, 2011